← Leaderboards
Eleanor Barnes
Johns Hopkins University
$1,408,431
Attributed
$1,408,431
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $311.9K · FY2021–25$500K$375K$250K$125K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,408,431 · 2
By mechanism
U19$1,408,431 · 2
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- David L Thomas$44,227,388
- Andrea L Cox$41,369,991
- Shruti H Mehta$41,677,787
- Justin Richard Bailey$16,021,335
- Stuart C Ray$7,743,036
Others in their field
Other Emerging Leaders on “Acute”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$51,003,204
- Julie Ake · National Institute Of Allergy And Infectious Diseases$41,692,120
- Xinhua Li · Nano Terra, Inc.$29,991,620
- Wendy Sammons-Jackson · National Institute Of Allergy And Infectious Diseases$29,269,420
- Evan Z Macosko · Broad Institute, Inc.$27,107,011
Research focus
AcuteGeneticAntibody ResponseAdenovirus VectorFutureAntiviral ImmunityBioinformaticsB-LymphocytesAntigensCd8-Positive T-LymphocytesAnti-Hepatitis CAdjuvantChronic InfectionCicatrixClinical TrialsConserved SequenceCovid-19 VaccineCross ReactivityDesignDetectionEfficacy TrialEpitopesE ProteinGenetic Variation
Grant awards (5)
The development and pre-clinical assessment of novel HCV vaccines to generate T and B cell immunity$311,926
U19 · FY2025 · AI · contact PI
The development and pre-clinical assessment of novel HCV vaccines to generate T and B cell immunity$257,316
U19 · FY2024 · AI · contact PI
The development and pre-clinical assessment of novel HCV vaccines to generate T and B cell immunity$265,020
U19 · FY2023 · AI · contact PI
The development and pre-clinical assessment of novel HCV vaccines to generate T and B cell immunity$285,297
U19 · FY2022 · AI · contact PI
The development and pre-clinical assessment of novel HCV vaccines to generate T and B cell immunity$288,872
U19 · FY2021 · AI · contact PI